Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMRI and early antidepressant response in major depressive disorder
2013-003370-27Phase 4Completed
- Sponsor
- Rainer Rupprecht, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of escitalopram, mirtazapine and agomelatine in major depressive disorder (MDD) (4 arms), sponsored by Rainer Rupprecht, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum. Started Jul 2014; status: completed.
02
Drugs
escitaloprammirtazapineagomelatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2013-003370-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003370-27.